Mitoxantrone Terminated Phase 3 Trials for Follicular Lymphoma (FL) Health Services Research

IndicationsStatusPurposePhase
TerminatedHealth Services Research3
clinicaltrials.gov IdentifierTitleDrugs
NCT00562965Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)